| 000 | 01559 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513205903.0 | ||
| 264 | 0 | _c20000606 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0012-186X | ||
| 024 | 7 |
_a10.1007/s001250050049 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHedrick, C C | |
| 245 | 0 | 0 |
_aGlycation impairs high-density lipoprotein function. _h[electronic resource] |
| 260 |
_bDiabetologia _cMar 2000 |
||
| 300 |
_a312-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAorta _xcytology |
| 650 | 0 | 4 | _aAryldialkylphosphatase |
| 650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xmetabolism |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 |
_aEsterases _xmetabolism |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipase _xmetabolism |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xmetabolism |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xpharmacology |
| 650 | 0 | 4 |
_aLiver _xenzymology |
| 650 | 0 | 4 |
_aMonocytes _xphysiology |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aThorpe, S R | |
| 700 | 1 | _aFu, M X | |
| 700 | 1 | _aHarper, C M | |
| 700 | 1 | _aYoo, J | |
| 700 | 1 | _aKim, S M | |
| 700 | 1 | _aWong, H | |
| 700 | 1 | _aPeters, A L | |
| 773 | 0 |
_tDiabetologia _gvol. 43 _gno. 3 _gp. 312-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s001250050049 _zAvailable from publisher's website |
| 999 |
_c10721247 _d10721247 |
||